Works matching AU Kameda, Hideto

Results: 104

2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication.

Published in:

Modern Rheumatology, 2025, v. 35, n. 3, p. 387, doi. 10.1093/mr/roaf006

By:

Harigai, Masayoshi;
Kaneko, Yuko;
Tanaka, Eiichi;
Hirata, Shintaro;
Kameda, Hideto;
Kaneko, Kayoko;
Kishimoto, Mitsumasa;
Kohno, Masataka;
Kojima, Masayo;
Kojima, Toshihisa;
Morinobu, Akio;
Nakajima, Ayako;
Sugihara, Takahiko;
Fusama, Mie;
Yajima, Nobuyuki;
Yanai, Ryo;
Kawahito, Yutaka

Publication type:

Article

Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials.

Published in:

Rheumatology & Therapy, 2025, v. 12, n. 2, p. 381, doi. 10.1007/s40744-025-00748-8

By:

Kristensen, Lars-Erik;
McGonagle, Dennis;
Rudwaleit, Martin;
Kameda, Hideto;
Würtzen, Peter Adler;
Ngantcha, Marcus;
Holzkämper, Thorsten;
Smolen, Josef

Publication type:

Article

Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY).

Published in:

Rheumatology & Therapy, 2025, v. 12, n. 3, p. 493, doi. 10.1007/s40744-025-00749-7

By:

Kameda, Hideto;
Ishii, Kentaro;
Kiriyama, Junna;
Mikami, Toshiaki;
Uratsuji, Hideya;
Morita, Akimichi

Publication type:

Article

Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).

Published in:

2024

By:

Kameda, Hideto;
Hagimori, Kohei;
Morisaki, Yoji;
Holzkämper, Thorsten;
Konomi, Ayako;
Dobashi, Hiroaki

Publication type:

Correction Notice

Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1683, doi. 10.1007/s40744-023-00605-6

By:

Kameda, Hideto;
Hagimori, Kohei;
Morisaki, Yoji;
Holzkämper, Thorsten;
Konomi, Ayako;
Dobashi, Hiroaki

Publication type:

Article

Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database.

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 10, p. 1967, doi. 10.1111/1756-185X.14848

By:

Kaneko, Yuko;
Kameda, Hideto;
Ikeda, Kei;
Yamashita, Katsuhisa;
Ozaki, Ryoto;
Tanaka, Yoshiya

Publication type:

Article

A comparative study of PF‐06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis.

Published in:

International Journal of Rheumatic Diseases, 2020, v. 23, n. 7, p. 876, doi. 10.1111/1756-185X.13846

By:

Kameda, Hideto;
Uechi, Eishi;
Atsumi, Tatsuya;
Abud‐Mendoza, Carlos;
Kamei, Kazumasa;
Matsumoto, Tsugumi;
Ponce de Leon, Dario;
Rehman, Muhammad I.;
Zhang, Min;
Radominski, Sebastiao C.

Publication type:

Article

Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post hoc analysis of Japanese Phase 3 clinical trials.

Published in:

Modern Rheumatology, 2025, v. 35, n. 1, p. 34, doi. 10.1093/mr/roae057

By:

Yoshiya Tanaka;
Toshiya Takahashi;
van Hoogstraten, Hubert;
Naoto Kato;
Hideto Kameda

Publication type:

Article

The effects of sarilumab as monotherapy and in combination with non-methotrexate disease-modifying anti-rheumatic drugs on unacceptable pain in patients with rheumatoid arthritis: A post-hoc analysis of the HARUKA phase 3 study.

Published in:

Modern Rheumatology, 2025, v. 35, n. 1, p. 27, doi. 10.1093/mr/roae055

By:

Yoshiya Tanaka;
Toshiya Takahashi;
van Hoogstraten, Hubert;
Naoto Kato;
Hideto Kameda

Publication type:

Article

Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance study.

Published in:

Modern Rheumatology, 2025, v. 35, n. 1, p. 42, doi. 10.1093/mr/roae051

By:

Hideto Kameda;
Sadatomo Tasaka;
Toshiya Takahashi;
Katsuhisa Suzuki;
Naoki Soeda;
Hubert;
van Hoogstraten;
Diab, Remco;
Yoshiya Tanaka

Publication type:

Article

Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus.

Published in:

Modern Rheumatology, 2024, v. 34, n. 6, p. 1170, doi. 10.1093/mr/roae029

By:

Hatano, Mika;
Yajima, Nobuyuki;
Yanai, Ryo;
Ishii, Sho;
Tsujimoto, Yasushi;
Azuma, Teruhisa;
Atsumi, Tatsuya;
Kaneko, Yuko;
Kameda, Hideto;
Kuwana, Masataka;
Tanaka, Yoshiya;
Nakagawa, Shiori;
Nakajima, Ayako;
Hiramatsu, Yuri;
Fujita, Daisuke;
Miyamae, Takako;
Murashima, Atsuko

Publication type:

Article

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study.

Published in:

Modern Rheumatology, 2024, v. 34, n. 6, p. 1103, doi. 10.1093/mr/roae019

By:

Kameda, Hideto;
Nishida, Keiichiro;
Nanki, Toshihiro;
Watanabe, Akira;
Oshima, Yukiya;
Momohara, Shigeki

Publication type:

Article

Effect of sarilumab on unacceptable pain and inflammation control in Japanese patients with moderately-to-severely active rheumatoid arthritis: Post hoc analysis of a Phase III study (KAKEHASI).

Published in:

Modern Rheumatology, 2024, v. 34, n. 4, p. 670, doi. 10.1093/mr/road073

By:

Yoshiya Tanaka;
Toshiya Takahashi;
van Hoogstraten, Hubert;
Naoto Kato;
Hideto Kameda

Publication type:

Article

Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance.

Published in:

Modern Rheumatology, 2024, v. 34, n. 3, p. 444, doi. 10.1093/mr/road055

By:

Kameda, Hideto;
Tasaka, Sadatomo;
Takahashi, Toshiya;
Suzuki, Katsuhisa;
Soeda, Naoki;
Tanaka, Yoshiya

Publication type:

Article

Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication.

Published in:

Modern Rheumatology, 2024, v. 34, n. 1, p. 1, doi. 10.1093/mr/road098

By:

Kameda, Hideto;
Yamaoka, Kunihiro;
Yamanishi, Yuji;
Tada, Masahiro;
Koike, Ryuji;
Nakajima, Ayako;
Fusama, Mie;
Fujii, Takao

Publication type:

Article

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study.

Published in:

Modern Rheumatology, 2023, v. 33, n. 3, p. 460, doi. 10.1093/mr/roac073

By:

Hideto Kameda;
Keiichiro Nishida;
Toshihiro Nanki;
Akira Watanabe;
Yukiya Oshima;
Shigeki Momohara

Publication type:

Article

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study.

Published in:

Modern Rheumatology, 2023, v. 33, n. 3, p. 460, doi. 10.1093/mr/roac073

By:

Hideto Kameda;
Keiichiro Nishida;
Toshihiro Nanki;
AkiraWatanabe;
Yukiya Oshima;
Shigeki Momohara

Publication type:

Article

A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan.

Published in:

Modern Rheumatology, 2022, v. 32, n. 5, p. 960, doi. 10.1093/mr/roab096

By:

Yuri Matsubara;
Yosikazu Nakamura;
Naoto Tamura;
Hideto Kameda;
Kotaro Otomo;
Mitsumasa Kishimoto;
Yuho Kadono;
Shigeyoshi Tsuji;
Tatsuya Atsumi;
Hiroaki Matsuno;
Michiaki Takagi;
Shigeto Kobayashi;
Keishi Fujio;
Norihiro Nishimoto;
Nami Okamoto;
Ayako Nakajima;
Kiyoshi Matsui;
Masahiro Yamamura;
Yasuharu Nakashima;
Atsushi Kawakami

Publication type:

Article

Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 686, doi. 10.1093/mr/roab066

By:

Yoshiya Tanaka;
Toshiya Takahashi;
Mariko Sumi;
Owen Hagino;
Van Hoogstraten, Hubert;
Xu, Christine;
Naoto Kato;
Hideto Kameda

Publication type:

Article

Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis.

Published in:

Modern Rheumatology, 2021, v. 31, n. 6, p. 1079, doi. 10.1080/14397595.2021.1879429

By:

Satoshi Muto;
Nana Minamitani;
Takehisa Ogura;
Arata Nakajima;
Koichi Nakagawa;
Toru Masaka;
Sumiko Hiura;
Hideki Kobayashi;
Hiroyoshi Kato;
Hideto Kameda

Publication type:

Article

Non-radiographic axial spondyloarthritis.

Published in:

Modern Rheumatology, 2021, v. 31, n. 2, p. 277, doi. 10.1080/14397595.2020.1830512

By:

Hideto Kameda;
Shigeto Kobayashi;
Naoto Tamura;
Yuho Kadono;
Kurisu Tada;
Masahiro Yamamura;
Tetsuya Tomita

Publication type:

Article

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases.

Published in:

Modern Rheumatology, 2021, v. 31, n. 1, p. 29, doi. 10.1080/14397595.2019.1709944

By:

Yoshiya Tanaka;
Masataka Kuwana;
Takao Fujii;
Hideto Kameda;
Yoshinao Muro;
Keishi Fujio;
Yasuhiko Itoh;
Hidekata Yasuoka;
Shusaku Fukaya;
Konomi Ashihara;
Daisuke Hirano;
Koichiro Ohmura;
Yuya Tabuchi;
Hisanori Hasegawa;
Ryo Matsumiya;
Yuichiro Shirai;
Takehisa Ogura;
Yumi Tsuchida;
Mariko Ogawa-Momohara;
Hidehiko Narazaki

Publication type:

Article

Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.

Published in:

Modern Rheumatology, 2021, v. 31, n. 1, p. 42, doi. 10.1080/14397595.2019.1709681

By:

Yoshiya Tanaka;
Hideto Kameda;
Kazuyoshi Saito;
Yuko Kaneko;
Eiichi Tanaka;
Shinsuke Yasuda;
Naoto Tamura;
Keishi Fujio;
Takao Fujii;
Toshihisa Kojima;
Tatsuhiko Anzai;
Chikuma Hamada;
Yoshihisa Fujino;
Shinya Matsuda;
Hitoshi Kohsaka

Publication type:

Article

The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method.

Published in:

Modern Rheumatology, 2020, v. 30, n. 3, p. 528, doi. 10.1080/14397595.2019.1621419

By:

Nobuyuki Yajima;
Yasushi Tsujimoto;
Shingo Fukuma;
Ken-ei Sada;
Sayaka Shimizu;
Kakuya Niihata;
Ryo Takahashi;
Yoshihide Asano;
Teruhisa Azuma;
Hideto Kameda;
Masataka Kuwana;
Hitoshi Kohsaka;
Mayumi Sugiura-Ogasawara;
Katsuya Suzuki;
Tsutomu Takeuchi;
Yoshiya Tanaka;
Naoto Tamura;
Toshihiro Matsui;
Tsuneyo Mimori;
Shunichi Fukuhara

Publication type:

Article

Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.

Published in:

Modern Rheumatology, 2020, v. 30, n. 3, p. 558, doi. 10.1080/14397595.2019.1619220

By:

Sayaka Takenaka;
Takehisa Ogura;
Hisaji Oshima;
Keisuke Izumi;
Ayako Hirata;
Hideki Ito;
Kennosuke Mizushina;
Yuki Inoue;
Takaharu Katagiri;
Norihide Hayashi;
Hideto Kameda

Publication type:

Article

Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA).

Published in:

Modern Rheumatology, 2020, v. 30, n. 2, p. 239, doi. 10.1080/14397595.2019.1639939

By:

Hideto Kameda;
Kazuteru Wada;
Yoshinori Takahashi;
Hagino, Owen;
van Hoogstraten, Hubert;
Graham, Neil;
Yoshiya Tanaka

Publication type:

Article

Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis.

Published in:

Modern Rheumatology, 2019, v. 29, n. 1, p. 31, doi. 10.1080/14397595.2018.1472358

By:

Hideto Kameda;
Takao Fujii;
Ayako Nakajima;
Ryuji Koike;
Akira Sagawa;
Katsuaki Kanbe;
Tetsuya Tomita;
Masayoshi Harigai;
Yasuo Suzuki

Publication type:

Article

Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.

Published in:

Modern Rheumatology, 2018, v. 28, n. 5, p. 780, doi. 10.1080/14397595.2017.1416760

By:

Tatsuya Atsumi;
Keishi Fujio;
Kunihiro Yamaoka;
Minako Tomobe;
Kazuyuki Kuroyanagi;
Hideto Kameda

Publication type:

Article

Fcγ receptor 3B polymorphism is associated with hypersensitivity reactions to adalimumab in Japanese patients with rheumatoid arthritis.

Published in:

Modern Rheumatology, 2017, v. 27, n. 5, p. 778, doi. 10.1080/14397595.2016.1254709

By:

Masako Tsukamoto;
Hideto Kameda;
Tatsuhiro Ohshige;
Yuko Kaneko;
Keiko Yoshimoto;
Katsuya Suzuki;
Tsutomu Takeuchi

Publication type:

Article

Possible preventive effect of salazosulfapyridine against development of Pneumocystis pneumonia in methotrexate-receiving patients with rheumatoid arthritis.

Published in:

Modern Rheumatology, 2016, v. 26, n. 6, p. 976, doi. 10.3109/14397595.2015.1118196

By:

Kennosuke Mizushina;
Ayako Hirata;
Norihide Hayashi;
Sayaka Takenaka;
Hideki Ito;
Takehisa Ogura;
Yuki Fujisawa;
Munetsugu Imamura;
Naoko Yamashita;
Rie Kujime;
Sumie Nakahashi;
Hideto Kameda

Publication type:

Article

Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.

Published in:

Modern Rheumatology, 2015, v. 25, n. 4, p. 609, doi. 10.3109/14397595.2014.980384

By:

Tanaka, Michi;
Koike, Ryuji;
Sakai, Ryoko;
Saito, Kazuyoshi;
Hirata, Shintaro;
Nagasawa, Hayato;
Kameda, Hideto;
Hara, Masako;
Kawaguchi, Yasushi;
Tohma, Shigeto;
Takasaki, Yoshinari;
Dohi, Makoto;
Nishioka, Yasuhiko;
Yasuda, Shinsuke;
Miyazaki, Yasunari;
Kaneko, Yuko;
Nanki, Toshihiro;
Watanabe, Kaori;
Yamazaki, Hayato;
Miyasaka, Nobuyuki

Publication type:

Article

The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.

Published in:

Modern Rheumatology, 2015, v. 25, n. 3, p. 401, doi. 10.3109/14397595.2014.973659

By:

Nishina, Naoshi;
Kaneko, Yuko;
Kameda, Hideto;
Takeuchi, Tsutomu

Publication type:

Article

Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: A single-center retrospective cohort study (KEIO-TCZ study) at week 52

Published in:

Modern Rheumatology, 2015, v. 25, n. 1, p. 31, doi. 10.3109/14397595.2014.897793

By:

Izumi, Keisuke;
Kaneko, Yuko;
Yasuoka, Hidekata;
Seta, Noriyuki;
Kameda, Hideto;
Kuwana, Masataka;
Takeuchi, Tsutomu

Publication type:

Article

Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial.

Published in:

Modern Rheumatology, 2014, v. 24, n. 4, p. 561, doi. 10.3109/14397595.2013.844886

By:

Kurasawa, Takahiko;
Nagasawa, Hayato;
Kishimoto, Mayumi;
Amano, Koichi;
Takeuchi, Tsutomu;
Kameda, Hideto

Publication type:

Article

Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.

Published in:

Modern Rheumatology, 2014, v. 24, n. 3, p. 399, doi. 10.3109/14397595.2013.843757

By:

Tanaka, Yoshiya;
Takeuchi, Tsutomu;
Amano, Koichi;
Saito, Kazuyoshi;
Hanami, Kentaro;
Nawata, Masao;
Fukuyo, Shunsuke;
Kameda, Hideto;
Kaneko, Yuko;
Kurasawa, Takahiko;
Nagasawa, Hayato;
Hoshi, Daisuke;
Sato, Eri;
Yamanaka, Hisashi

Publication type:

Article

Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.

Published in:

Modern Rheumatology, 2013, v. 23, n. 2, p. 284, doi. 10.3109/s10165-012-0657-2

By:

Harigai, Masayoshi;
Takamura, Akito;
Atsumi, Tatsuya;
Dohi, Makoto;
Hirata, Shintaro;
Kameda, Hideto;
Nagasawa, Hayato;
Seto, Yohei;
Koike, Takao;
Miyasaka, Nobuyuki

Publication type:

Article

A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.

Published in:

Modern Rheumatology, 2013, v. 23, n. 2, p. 297, doi. 10.3109/s10165-012-0658-1

By:

Takamura, Akito;
Hirata, Shintaro;
Nagasawa, Hayato;
Kameda, Hideto;
Seto, Yohei;
Atsumi, Tatsuya;
Dohi, Makoto;
Koike, Takao;
Miyasaka, Nobuyuki;
Harigai, Masayoshi

Publication type:

Article

Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.

Published in:

Modern Rheumatology, 2013, v. 23, n. 1, p. 97, doi. 10.3109/s10165-012-0645-6

By:

Nishi, Eiko;
Kameda, Hideto;
Ogawa, Hiroe;
Nagasawa, Hayato;
Takei, Hirofumi;
Okuyama, Ayumi;
Kurasawa, Takahiko;
Kondo, Tsuneo;
Nishimura, Koji;
Shirai, Yuichiro;
Sakai, Ryota;
Ito, Tatsuya;
Takeuchi, Tsutomu;
Amano, Koichi

Publication type:

Article

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).

Published in:

Modern Rheumatology, 2012, v. 22, n. 3, p. 327, doi. 10.3109/s10165-011-0516-6

By:

Takeuchi, Tsutomu;
Tanaka, Yoshiya;
Kaneko, Yuko;
Tanaka, Eiichi;
Hirata, Shintaro;
Kurasawa, Takahiko;
Kubo, Satoshi;
Saito, Kazuyoshi;
Shidara, Kumi;
Kimura, Noriko;
Nagasawa, Hayato;
Kameda, Hideto;
Amano, Koichi;
Yamanaka, Hisashi

Publication type:

Article

Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept.

Published in:

Modern Rheumatology, 2012, v. 22, n. 2, p. 186, doi. 10.3109/s10165-011-0510-z

By:

Tanaka, Yoshiya;
Yamanaka, Hisashi;
Saito, Kazuyoshi;
Iwata, Shigeru;
Miyagawa, Ippei;
Seto, Yohei;
Momohara, Shigeki;
Nagasawa, Hayato;
Kameda, Hideto;
Kaneko, Yuko;
Izumi, Keisuke;
Amano, Koichi;
Takeuchi, Tsutomu

Publication type:

Article

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).

Published in:

Modern Rheumatology, 2011, v. 21, n. 2, p. 122, doi. 10.3109/s10165-010-0366-7

By:

Yamanaka, Hisashi;
Tanaka, Yoshiya;
Inoue, Eisuke;
Hoshi, Daisuke;
Momohara, Shigeki;
Hanami, Kentaro;
Yunoue, Naoki;
Saito, Kazuyoshi;
Amano, Kouichi;
Kameda, Hideto;
Takeuchi, Tsutomu

Publication type:

Article

Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.

Published in:

Modern Rheumatology, 2010, v. 20, n. 6, p. 531, doi. 10.1007/s10165-010-0324-4

By:

Kameda, Hideto;
Ueki, Yukitaka;
Saito, Kazuyoshi;
Nagaoka, Shouhei;
Hidaka, Toshihiko;
Atsumi, Tatsuya;
Tsukano, Michishi;
Kasama, Tsuyoshi;
Shiozawa, Shunichi;
Tanaka, Yoshiya;
Takeuchi, Tsutomu

Publication type:

Article

Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis.

Published in:

Modern Rheumatology, 2010, v. 20, n. 4, p. 337, doi. 10.3109/s10165-010-0284-8

By:

Nagasawa, Hayato;
Kameda, Hideto;
Sekiguchi, Naoya;
Amano, Koichi;
Takeuchi, Tsutomu

Publication type:

Article

Improvement of the HAQ score by infliximab treatment in patients with RA: its association with disease activity and joint destruction.

Published in:

Modern Rheumatology, 2009, v. 19, n. 2, p. 166, doi. 10.3109/s10165-008-0142-0

By:

Nagasawa, Hayato;
Kameda, Hideto;
Sakiguchi, Neoya;
Amano, Kouichi;
Takeuchi, Tsutomu

Publication type:

Article

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).

Published in:

Modern Rheumatology, 2008, v. 18, n. 5, p. 447, doi. 10.3109/s10165-008-0077-5

By:

Takeuchi, Tsutomu;
Yamanaka, Hisashi;
Inoue, Eisuke;
Nagasawa, Hayato;
Nawata, Masao;
Ikari, Katsunori;
Saito, Kazuyoshi;
Sekiguchi, Naoya;
Sato, Eri;
Kameda, Hideto;
Iwata, Shigeru;
Mochizuki, Takeshi;
Amano, Kouichi;
Tanaka, Yoshiya

Publication type:

Article

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs.

Published in:

Drugs - Real World Outcomes, 2018, v. 5, n. 3, p. 169, doi. 10.1007/s40801-018-0139-8

By:

Sruamsiri, Rosarin;
Kameda, Hideto;
Mahlich, Jörg

Publication type:

Article

Giant cell arteritis with polymyalgia rheumatica on FDG- PET/ CT.

Published in:

Clinical Case Reports, 2017, v. 5, n. 7, p. 1186, doi. 10.1002/ccr3.994

By:

Baba, Akira;
Uno, Kimiichi;
Okuyama, Yumi;
Munetomo, Yohei;
Nakajima, Shintaro;
Mizushina, Kennosuke;
Kameda, Hideto

Publication type:

Article

Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus.

Published in:

Rheumatology International, 2011, v. 31, n. 6, p. 757, doi. 10.1007/s00296-010-1366-9

By:

Suzuki, Katsuya;
Kameda, Hideto;
Amano, Koichi;
Nagasawa, Hayato;
Takei, Hirofumi;
Nishi, Eiko;
Okuyama, Ayumi;
Tsuzaka, Kensei;
Takeuchi, Tsutomu

Publication type:

Article

Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis.

Published in:

Rheumatology International, 2009, v. 29, n. 4, p. 431, doi. 10.1007/s00296-008-0833-z

By:

Suzuki, Katsuya;
Kameda, Hideto;
Amano, Koichi;
Nagasawa, Hayato;
Takei, Hirofumi;
Sekiguchi, Naoya;
Nishi, Eiko;
Ogawa, Hiroe;
Tsuzaka, Kensei;
Takeuchi, Tsutomu

Publication type:

Article

Cartilage evaluation by ultrasonography in patients with rheumatoid arthritis: a scoping review.

Published in:

Inflammation & Regeneration, 2023, v. 43, n. 1, p. 1, doi. 10.1186/s41232-023-00286-2

By:

Ogura, Takehisa;
Katagiri, Takaharu;
Kameda, Hideto

Publication type:

Article